Healthcare costs; HIV AIDS; Predictive factors; Healthcare consumption; Coûts de soins de santé; HIV Sida; Facteurs prédictifs; Consommation de soins
Abstract :
[en] Introduction: This article analyses the composition of healthcare costs for HIV/AIDS infected patients in a country with limited resources and attempts to identify the factors that influence these costs. The aims are to calculate medical care costs, analysing how they vary depending on patients' income, and to evaluate the factors explaining healthcare consumption.
Methods: This is a prospective cohort study focusing on patients who were admitted to hospital for a short stay between January 2010 and June 2011, before their integration into a specialised program. The patients were selected randomly. Free consent was obtained from all participants. Data were analysed using the SPSS 19.0 software. The significance threshold was set at 5% and the CI (Confidence Interval) at 95%. We used Kruskal-Wallis tests, Fisher's
exact test and multiple linear regression.
Results: We monitored 209 patients. Their average age was 36.37 years (SD: 8.72). The sex ratio was 0.58 and the women patients were generally younger than the male ones (p=0.011). The overall cost of healthcare amounted to $US 41,922. The cost of Antiretroviral Therapy represented 21.6% ($US 9,045). The price of para-clinical examinations represented 46% ($US 19,136) of the overall cost. The patient's average monthly income was $US 157.40 whereas the
average direct cost per patient was$US 201.45. Both monthly income (t=4.385; p=0.0000) and education level (t=3.703 p=0.0003) were statistically significant predictive factors for healthcare consumption. The medical care costs for patients with opportunistic infections were nine times higher than those for patients who presented none. The presence of opportunistic infections increased healthcare consumption by approximately 31$ US (CI 95%: 15-46.9).
Conclusion: The average direct cost for patients on each short-term stay was higher than the average monthly income.
To be able to access the necessary services, the patients need additional resources, which are derived from various sources. Monthly income and the level of education were both statistically significant predictors for healthcare consumption. The analysis allows us to extend the study by using different analytical accounting approaches such as by case and by pathology.
Research Center/Unit :
CEPE - Centre d'Études de la Performance des Entreprises - ULiège
Disciplines :
Public health, health care sciences & services Accounting & auditing
Author, co-author :
Mundongo Tshamba, Henri; Université de Lubumbashi
Mukeng a Kaut, Clarence; Université de Lubumbashi
Mulubwa Kyalubile, Nono; ISTM Lubumbashi
Kaj Kakamba, Alphonse; Université de Lubumbashi
Ditend Yav, Grévisse; Université de Lubumbashi
Kaj Malonga, Françoise; Université de Lubumbashi
Van Caillie, Didier ; Université de Liège - ULiège > HEC-Ecole de gestion : UER > Diagnostic et contrôle de l'entreprise
Language :
English
Title :
Cost of hospital care for HIV/AIDS infected patients in three general reference hospitals in Lubumbashi, DR Congo: prospective cohort study
Alternative titles :
[fr] Le coût des soins hospitaliers des patients infectés par le SIDA/HIV dans 3 hôpitaux généraux de référence à Lubumbashi, RDC : une étude prospective par cohorte
Publication date :
26 June 2013
Journal title :
Pan African Medical Journal
eISSN :
1937-8688
Publisher :
African Field Epidemiology Network, Kampala, Uganda
Clumeck, N., Mwamba, M., Kabeya, K., Mafutamingi, J., Vaira, D., Ilunga, K., The Lubumbashi trial, Lopinavir versus Nevirapine-based regimens in treatment-naïve patients in a Developing country (2011) 13th European AIDS Conference, , 12-15 October, Belgrade. EACS
Kim, A., HIV infection among internally displaced women residing in river populations along the congo river (2009) D.R. Congo. AIDS Behav., 13 (5), pp. 914-920. , PubMed | Google Scholar
Wandeler, G., Keiser, O., Boule, A., Mulenga, L., Wood, R., Prozesky, H., Tenofovir in second line antiretroviral therapy in southern Africa, collaborative analysis of cohort studies (2011) 13th European AIDS Conference, , 12-15 October, Belgrade. EACS
(2004) Rapport du programme des Nations Unies sur le VIH-SIDA, , http://www.unaids.org/globalreport/documents/20101123, ONUSIDA-OMS, Accessed 13 April 2013
Ray, Y.C., Neil, A.A., Andrew, O., Distribution of health care expenditures for HIV infected patients (2006) Clin Infect Dis., 42 (7), pp. 1003-1010. , PubMed | Google Scholar
Palella, F., Delaney, K., Moorman, A., Loveless, M., Fuhrer, J., Satten, G., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators (1998) N Engl J Med., 338 (13), pp. 853-860. , PubMed | Google Scholar
Streinbrook, R., Providing antiretroviral therapy of HIV infection (2001) N Engl J Med., 344 (11), pp. 844-846. , PubMed | Google Scholar
Moore, R., Cost effectiveness of combinaison HIV therapy: 3 years later (2000) Pharmacoeconomics., 17 (4), pp. 325-330. , PubMed | Google Scholar
Ambrosioni, J., Thomas, J., Delhumeau, C., Alexandra, C., Bernard, H., Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections (2012) AIDS., 26 (16), pp. 2079-2086. , PubMed | Google Scholar
Yeni, P., Hammer, S., Carpenter, C., Antiretroviral treatment for adult HIV-Infected in 2002, updated recommendations of the international AIDS society-USA Panel (2002) JAMA., 288 (2), pp. 222-235. , PubMed | Google Scholar
Sempowski, G., Haynes, B., Immune reconstitution in patients with HIV infection (2002) Ann Rev Med., 53, pp. 269-284. , PubMed | Google Scholar
Poulin, J., Viswanathan, M., Harris, J., Komanduri, K., Wieder, E., Ringuette, N., Direct evidence for thymic function in adult humans (1999) J Exp Med., 190 (4), pp. 479-485. , PubMed | Google Scholar
Schackman, B., Freedberg, K., Weinstein, M., Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-Infected adults (2002) Arch Intern Med., 162 (21), pp. 2478-2486. , PubMed | Google Scholar
Corbett, E.L., Steketee, R.W., HIV-1/AIDS and the control of other infectious diseases in Africa (2002) Lancet., 359 (9324), pp. 2177-2187. , PubMed | Google Scholar
(2009) Rapport mondial sur le développement humain, programme de Nations Unies pour le développement, , http://www.dj.undp.org/pages/Off_Doc_Agr/HDR, PNUD. Accessed 15 April 2013
Nobre, T., Biron, N., L'ABC à l'hôpital: Le cas de la chirurgie infantile (2002) Finance Contrôle Stratégie., 5 (2), pp. 85-105. , PubMed | Google Scholar
Baker, J., (1998) Activity-Based Costing and Activity-Based Management for health care, , NY, USA. Aspen Publishers. Google Scholar
Forgione, D., Vermeer, T., Surysekar, K., DRGs costs and quality of care, an agency theory perspective (2005) Finance Account Man., 21 (3), pp. 291-308. , PubMed | Google Scholar
Halgand, N., (2000) La comptabilité hospitalière, encyclopedie de comptabilité, de contrôle de gestion et d'audit, , Paris. Economica. Google Scholar
Udpa, S., Activity-Based Costing for hospital health care (1996) Management Review., 21 (3), pp. 83-96. , PubMed | Google Scholar
Dawson, D., Gravelle, H., Jacobs, R., Martin, S., Smith, P., The effects of expanding patient choice of provider on waiting times, evidence from a policy experiment (2007) Health Econ., 16 (2), pp. 113-128. , PubMed | Google Scholar
Kjerstard, E., Prospective funding of general hospitals in Norway, incentives for higher production? (2003) Int J Health care Finance Econ., 3 (4), pp. 231-251. , Google Scholar
Velasco, M., Losa, J., Espinosa, A., Sanz, J., Gaspar, G., Cervero, M., Economic evaluation of assistance to HIV patients in Spanish hospital (2007) European Journal of Internal Medicine., 18 (5), pp. 400-404. , PubMed | Google Scholar
Engel, F., Kletz, F., Moisdon, J., Tonneau, D., (2000) La demarche gestionnaire à l?hôpital, le PSMI, , Paris. Seli-Arslan
Bozette, S., Joyce, G., McCaffrey, D., Expenditures for the care of HIV-Infected patients in the era of highly active antiretroviral therapy (2001) N Engl J Med., 344 (11), pp. 817-823. , PubMed | Google Scholar
Binquet, C., Chene, G., Jacqmin, G.H., Journot, V., Saves, M., Lacoste, D., Modeling changes in CD4-positive T-Lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections, the Aquitaine cohort 1996-1997 (2001) Am J Epidem., 153 (4), pp. 386-393. , PubMed | Google Scholar
Carolina, G., Norma, R., Vincent, S., Mariola, L., Natalia, Z., Mechanisms involved in CD4 gains in HIV-Infected patients Switched to raltegravir (2012) AIDS., 26 (5). , PubMed | Google Scholar, 000-000
Corbeau, P., Immune reconstitution under antiretroviral therapy, the new challenge in HIV-1 infection (2011) Blood., 117 (21), pp. 5582-5590. , PubMed | Google Scholar
Barreiro, P., Soriano, V., Casas, E., Gonzalez, L.J., Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non nucleosides (2002) AIDS., 16 (2), pp. 245-249. , PubMed | Google Scholar
The cost to health service of human immunodefiency virus (HIV), coinfection among tuberculosis patients in Sudan (2006) Health Policy., 75 (3), pp. 272-279. , A I E L-Sony., PubMed | Google Scholar
Aracena, B., Gutierrez, J.P., Stefano, M.B., Gertler, P., Costs of AIDS care in Mexico: What are its main individual predictors? (2005) Arch of Med Research., 36 (5), pp. 560-566. , Google Scholar
Pedram, S., Schellenberg, F., Ungsedhapand, C., Gilbert, R.K., Heiner, C., Productivity cots and determinants of productivity in HIV-infected patients (2004) Clinical Therapeutics., 26 (5), pp. 791-800. , PubMed | Google Scholar
La croix, S.J., Russo, G., A cost-benefit analysis of voluntary routine HIV antibody testing for hospital patients (1996) Social Sciences Medicine., 42 (9), pp. 1259-1272. , PubMed | Google Scholar
Nashala, M., Lubaba, S., Mohammed, M., Sayera, B., Dilruba, A., (2011) Profil Clinique du VIH-SIDA chez les patients infectés admis dans une unite spécialisée à Dhaka au Bangladesh, 29 (1), pp. 14-19. , Google Scholar
Manga, N., Diop, S., Ndour, C., Dia, M., Mendy, A., Dépistage Tardif de l?infection à VIH à la clinique des maladies infectieuses de Fann à Dakar, circonstances de dépistage itinéraire thérapeutique des patients et facteurs déterminants (2009) Médicine et Maladies Infectieuses., 39 (2), pp. 95-100. , PubMed | Google Scholar
Zannou, D., Kindé, G., Vigan, G., Adè, J., Atadokpèdé, F., Profil Clinique et immunologique des patients infectés par le VIH dépistés à Cotonou au Benin (2004) Médecine et Maladies Infectieuses., 34 (5), pp. 225-228. , PubMed | Google Scholar
